Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
19.51
-1.58 (-7.49%)
Sep 20, 2024, 4:00 PM EDT - Market closed
Pharvaris Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 37.35 | 31.34 | 29.34 | 18.35 | 5.5 | 2.33 | |
Research & Development | 78.73 | 65.58 | 57.38 | 35.79 | 19.51 | 5.68 | |
Operating Expenses | 116.08 | 96.91 | 86.71 | 54.14 | 25.01 | 8.01 | |
Operating Income | -116.08 | -96.91 | -86.71 | -54.14 | -25.01 | -8.01 | |
Interest Expense | - | - | -0.02 | -0.27 | -0.09 | -0 | |
Interest & Investment Income | 2.31 | 0.22 | - | - | - | - | |
Currency Exchange Gain (Loss) | 0.95 | -3.12 | 11.1 | 11.76 | -0.96 | -0.01 | |
Other Non Operating Income (Expenses) | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 | -0 | |
Pretax Income | -112.85 | -99.83 | -75.65 | -42.66 | -26.07 | -8.03 | |
Income Tax Expense | 1.25 | 1.05 | 0.68 | 0.07 | -0.08 | - | |
Net Income | -114.1 | -100.88 | -76.33 | -42.73 | -25.99 | -8.03 | |
Net Income to Common | -114.1 | -100.88 | -76.33 | -42.73 | -25.99 | -8.03 | |
Shares Outstanding (Basic) | 48 | 38 | 34 | 30 | 5 | 5 | |
Shares Outstanding (Diluted) | 48 | 38 | 34 | 30 | 5 | 5 | |
Shares Change (YoY) | 41.83% | 14.31% | 10.44% | 527.05% | 0.30% | -0.30% | |
EPS (Basic) | -2.37 | -2.63 | -2.27 | -1.41 | -5.36 | -1.66 | |
EPS (Diluted) | -2.37 | -2.63 | -2.27 | -1.41 | -5.36 | -1.66 | |
Free Cash Flow | -99.38 | -93.14 | -67.29 | -44.73 | -21.54 | -6.69 | |
Free Cash Flow Per Share | -2.06 | -2.43 | -2.00 | -1.47 | -4.44 | -1.38 | |
EBITDA | -116.1 | -96.85 | -86.68 | -54.06 | -25 | -8.01 | |
D&A For EBITDA | -0.03 | 0.06 | 0.04 | 0.08 | 0.01 | 0 | |
EBIT | -116.08 | -96.91 | -86.71 | -54.14 | -25.01 | -8.01 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.